Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-25-028431
Filing Date
2025-12-19
Accepted
2025-12-19 06:15:24
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 form424b5.htm 424B5 801284
2 GRAPHIC form424b5_001.jpg GRAPHIC 10563
3 GRAPHIC form424b5_002.jpg GRAPHIC 51398
4 GRAPHIC form424b5_003.jpg GRAPHIC 65306
5 GRAPHIC form424b5_004.jpg GRAPHIC 52725
6 GRAPHIC form424b5_005.jpg GRAPHIC 44137
  Complete submission text file 0001493152-25-028431.txt   1111776
Mailing Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432
Business Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278874 | Film No.: 251584907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)